ATE140868T1 - Steigerung der fruchtbarkeit - Google Patents

Steigerung der fruchtbarkeit

Info

Publication number
ATE140868T1
ATE140868T1 AT90906746T AT90906746T ATE140868T1 AT E140868 T1 ATE140868 T1 AT E140868T1 AT 90906746 T AT90906746 T AT 90906746T AT 90906746 T AT90906746 T AT 90906746T AT E140868 T1 ATE140868 T1 AT E140868T1
Authority
AT
Austria
Prior art keywords
paf
pct
antagonist
homologue
uterus
Prior art date
Application number
AT90906746T
Other languages
English (en)
Inventor
Christopher O'neill
Original Assignee
North Sydney Area Health Serv
Oneill Christopher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North Sydney Area Health Serv, Oneill Christopher filed Critical North Sydney Area Health Serv
Application granted granted Critical
Publication of ATE140868T1 publication Critical patent/ATE140868T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Retarders (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT90906746T 1989-05-05 1990-05-07 Steigerung der fruchtbarkeit ATE140868T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPJ405489 1989-05-05

Publications (1)

Publication Number Publication Date
ATE140868T1 true ATE140868T1 (de) 1996-08-15

Family

ID=3773897

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90906746T ATE140868T1 (de) 1989-05-05 1990-05-07 Steigerung der fruchtbarkeit

Country Status (9)

Country Link
US (1) US5240922A (de)
EP (1) EP0473612B1 (de)
KR (1) KR920700648A (de)
AT (1) ATE140868T1 (de)
CA (1) CA2054197A1 (de)
DE (1) DE69027992D1 (de)
HU (1) HUT60631A (de)
NO (1) NO179125C (de)
WO (1) WO1990013299A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0540766A1 (de) * 1991-11-04 1993-05-12 Korth, Ruth-Maria, Dr. med Behandlung von Eosinophil-mediierten Erkrankungen mit PAF-Antagonisten, und Verfahren zur Bestimmung deren Effektivität
US5895785A (en) * 1987-10-20 1999-04-20 Ruth Korth Treatment and prevention of disorders mediated by LA-paf or endothelial cells
DE540767T1 (de) * 1991-11-04 2001-10-25 Ruth-Maria Korth Behandlung und Vorbeugung von von erhöhten Lyso-PAF-Spiegel mediierten mentalen Erkrankungen mit PAF-Antagonisten
GB9227123D0 (en) * 1992-12-30 1993-02-24 Applied Research Systems Method
US5654145A (en) * 1994-10-04 1997-08-05 La Jolla Cancer Research Foundation Trophinin and trophinin-assisting nucleic acids and methods of detection thereof
US5599918A (en) * 1994-10-04 1997-02-04 La Jolla Cancer Research Foundation Nucleic acids encoding trophinin and trophinin-assisting proteins
US6022563A (en) * 1998-02-04 2000-02-08 Superior Equine Pharmaceuticals, Inc. Phenylbutazone carrier formulation
AU2002258821A1 (en) * 2001-04-18 2002-11-05 Family Health International Vasectomy procedure and related kit
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
JP2005503425A (ja) * 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
ATE415155T1 (de) * 2001-05-24 2008-12-15 Alexza Pharmaceuticals Inc Verabreichung von alprazolam, estazolam, midazolam oder triazolam durch inhalation
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7498019B2 (en) 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
CA2518268C (en) * 2003-03-04 2013-12-10 Aspenbio, Inc. Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using luteinizing hormone
US20040234916A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
CN1871341A (zh) * 2003-08-20 2006-11-29 悉尼北方和中部海岸区医疗服务系统 提高胚胎生存力的方法
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP1781360A1 (de) 2004-08-12 2007-05-09 Alexza Pharmaceuticals, Inc. Aerosol-arzneiabgabevorrichtung mit perkussiv aktivierten wärmepackungen
US20070087055A1 (en) * 2005-10-14 2007-04-19 David Jan Directly compressible extended release alprazolam formulation
WO2008112661A2 (en) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
US20110021591A1 (en) * 2009-07-21 2011-01-27 Gordon Douglas J Phenylbutazone carrier formulation showing increased bioactivity in animals
KR101491595B1 (ko) 2010-07-12 2015-02-11 가부시키가이샤 에리나 ａｘｉａｌ―ｅｑｕａｔｏｒｉａｌ ａｒｙｌ배향의 ｆｕｒｏｆｕｒａｎ형 리그난을 함유하는 골 형성 촉진용 약학적 조성물 및 이의 조성물을 포함하는 약학적 제제, 기능성 식품 및 건강 식품
US11129851B2 (en) 2014-06-17 2021-09-28 Igenomix S.L. Stem cell therapy in endometrial pathologies
US12214118B2 (en) 2018-02-02 2025-02-04 Alexza Pharmaceuticals, Inc. Electrical condensation aerosol device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973603A (en) * 1988-06-16 1990-11-27 Sumner Burstein Platelet activating factor antagonist and methods of use therefor

Also Published As

Publication number Publication date
WO1990013299A1 (en) 1990-11-15
NO914306L (no) 1992-01-03
NO914306D0 (no) 1991-11-01
DE69027992D1 (de) 1996-09-05
NO179125B (no) 1996-05-06
NO179125C (no) 1996-08-14
EP0473612A1 (de) 1992-03-11
HU9004445D0 (en) 1992-02-28
EP0473612A4 (en) 1992-11-19
KR920700648A (ko) 1992-08-10
HUT60631A (en) 1992-10-28
US5240922A (en) 1993-08-31
EP0473612B1 (de) 1996-07-31
CA2054197A1 (en) 1990-11-06

Similar Documents

Publication Publication Date Title
ATE140868T1 (de) Steigerung der fruchtbarkeit
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
DE69033487D1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
IT1248702B (it) Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
ES2114605T5 (es) Metodo anticonceptivo que emplea un antagonista de progesterona competitivo y nuevos compuestos utilizados en el.
BR9406823A (pt) Aminas secundárias e agentes anti-diabéticos e antiobesidade
GR3019315T3 (en) Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders
OA09702A (en) The use of gaba-B selective agonists as antitussive agents.
ES521422A0 (es) Procedimiento para la obtencion de derivados de carboxilamida n-glicosilados.
FI930266A0 (fi) Vateriitti ja menetelmä sen valmistamiseksi
FI821804A0 (fi) Polysackarider baserade pao nytt anti-tromboticum, foerfarande foer dess framstaellning och farmaceutiska kompositioner
GB2210556B (en) The use of 15-keto-16-halo-prostaglandins in cathartic compositions
ATE150301T1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische zusammensetzungen davon zur prävention oder behandlung von herzerkrankungen
NO972623D0 (no) Framasöytisk blanding omfattende lamotrigin
DE3468682D1 (en) Amidines, process for their preparation and their therapeutical use
DE69002946D1 (de) Paracetamol enthaltende arzneizubereitung.
SE8903529D0 (sv) Medical use
ATE59778T1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
ATE98129T1 (de) Somatotropin zur steigerung der fertilitaet bei tieren.
DK527186A (da) Bronchodilaterende farmaceutisk praeparat
SE9403160D0 (sv) Method and means for prevention and treatment of secondary cataract
DE69220229D1 (de) Somatotropin zur erhoehung der reproduktiven leistung in rinder
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
SE9001592L (sv) Terapeutisk komposition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties